The impact of personal experiences with infection and vaccination on behaviour-incidence dynamics of seasonal influenza

Epidemics

Volumn 4, Issue 3, 2012, Pages 139-151

  Wells, C R ^a   Bauch, C T ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Behaviour incidence model; Game theory; Infectious disease; Influenza; Network model; Vaccinating behaviour

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL DECISION MAKING; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; HEALTH BEHAVIOR; HUMAN; INFLUENZA VACCINATION; LONG TERM MEMORY; MATHEMATICAL MODEL; MORBIDITY; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SEASONAL INFLUENZA; SELF EVALUATION; VACCINE FAILURE;

COMPUTER SIMULATION; DECISION MAKING; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; GAME THEORY; HEALTH BEHAVIOR; HUMANS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; SOCIAL ENVIRONMENT;

EID: 84864044474     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2012.06.002     Document Type: Article

References (62)

1. Akazawa M., Sindelar J., Paltiel A. Economic costs of influenza-related work absenteeism. Value in Health 2003, 6(2):107-115.
2. Ambrose C., Yi T., Walker R., Connor E. Duration of protection provided by live attenuated influenza vaccine in children. Pediatric Infectious Disease Journal 2008, 27(8):744-748.
3. Andersson H. Epidemics in a population with social structure. Mathematical Biosciences 1997, 140:79-84.
4. Bauch C.T., Bhattacharyya S. Evolutionary game theory and social learning can determine how vaccine scares unfold. PLoS Computational Biology 2012, 8(4):e1002452.
5. Bauch C.T., Earn D.J.D. Vaccination and the theory of games. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(36):13391-13394.
6. Bauch C.T. Imitation dynamics predict vaccinating behaviour. Proceedings of the Royal Society B: Biological Sciences 2005, 272(1573):1669-1675.
7. Bordon Y. Flu vaccine surplus. Nature Reviews Immunology 2010, 10(88).
8. Bridges C., Thompson W., Meltzer M., Reeve G., Talamonti W., Cox N., Lilac H., Hall H., Klimov A., Fukuda K. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. Journal of the American Medical Association 2000, 284(13).
9. Center for Disease Control and Prevention, 2012a. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). , February. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5208a1.htm.
10. Center for Disease Control and Prevention, 2012b. United States surveillance data: 1997-1998 through 2009-2010 seasons. , April. http://www.cdc.gov/flu/weekly/ussurvdata.htm.
11. Chapman G.B., Coups E.J. Predictors of influenza vaccine acceptance among healthy adults. Preventive Medicine 1999, 29(4):249-262.
12. Chapman G., Coups E. Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychology 2006, 25(1):82-90.
13. Chowell G., Viboud C., Munayco C., Gomez J., Simonsen L., Miller M., Tamerius J., Fiestas V., Halsey E., Laguna-Torres V. Spatial and temporal characteristics of the 2009 a/h1n1 influenza pandemic in Peru. PLoS ONE 2011, 6(6):e21287.
14. Cornforth D.M., Reluga T.C., Shim E., Bauch C.T., Galvani A.P., Meyers L.A. Erratic flu vaccination emerges from short-sighted behaviour in contact networks. PLoS Computational Biology 2011, 7(1):e1001062.
15. Couch R. Advances in influenza virus vaccine research. Annals of the New York Academy of Sciences 1993, 685:803-812.
16. Cox R.J., Brokstad K.A., Ogra P. Influenza virus: immunity and vaccination strategies. comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scandinavian Journal of Immunology 2004, 59:1-15.
17. Demicheli V., Pietrantonj C.D., Jefferson T., Rivetti A., Rivetti D. Vaccines for preventing influenza in healthy adults. Database of Systematic Reviews 2007, 2.
18. Dushoff J., Plotkin J., Viboud C., Simonsen L., Miller M., Loeb M., Earn D.D. Vaccinating to protect a vulnerable subpopulation. PLoS Medicine 2007, 4(5):921-927.
19. Earn D., Dushoff J., Levin S. Ecology and evolution of the flu. Trends in Ecology and Evolution 2002, 17(7):334-340.
20. Fedson D.S. Pandemic influenza and the global vaccine supply. Clinical Infectious Diseases 2003, 36(12):1552-1561.
21. Fiers W., Filette M.D., Birkett A., Neirynck S., Jou W.M. A universal human influenza a vaccine. Virus Research 2004, 103:173-176.
22. Fiore A., Uyeki T., Broder K., Finelli L., Euler G., Singleton J., Iskander J., Wortley P., Shay D., Bresee J., Cox N. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices. Morbidity and Mortality Weekly Report 2010, 59(RR-8):1-61.
23. Fleming D., Ayres J. Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice. Journal of the Royal College of General Practitioners 1988, 38(309):159-162.
24. Fu F., Rosenbloom D.I., Wang L., Nowak M.A. Imitation dynamics of vaccination behaviour on social networks. Proceedings of the Royal Society B: Biological Sciences 2011, 278(1702):42-49.
25. Funk S., Gilad E., Watkins C., Jansen V. The spread of awareness and its impact on epidemic outbreaks. Proceedings of the National Academy of Sciences of the United States of America 2009, 106(16):6872-6877.
26. Galvani A., Reluga T., Chapman G. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(13):5692-5697.
27. Kaiser J. Facing down pandemic flu, the world's defenses are weak. Science 2004, 306:394-397.
28. Kaiser J. A one-size-fits-all flu vaccine?. Science 2006, 312(5772):380-382.
29. Keech M., Scott A.J., Ryan P.J.J. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occupational Medicine 1998, 48(2):85-90.
30. Keeling M.J., Rand D.A., Morris A.J. Correlation models for childhood epidemics. Proceedings of the Royal Society B: Biological Sciences 1997, 264(1385):1149-1156.
31. Keeling M. The effects of local spatial structure on epidemiological invasions. Proceedings of the Royal Society B: Biological Sciences 1999, 266(1421):859-867.
32. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., Hess K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997, 15:1114-1122.
33. Kwong J.C., Rosella L., Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Reports 2007, 18(4):1-11.
34. Lee P.Y., Matchar D.B., Clements D.A., Huber J., Hamilton J.D., Peterson E.D. Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Annals of Internal Medicine 2002, 137(4):225-231.
35. Longini I.M., Halloran M.E., Nizam A., Wolff M., Mendelman P.M., Fast P.E., Belshe R.B. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 2000, 18:1902-1909.
36. Meltzer M.I., Cox N.J., Fukuda K. The economic impact of pandemic influenza in the united states: priorities for intervention. Emerging Infectious Diseases 1999, 5(5):659-671.
37. Merrill M., Hollister A., Gibbens S., Haynes A., Leslau V. Attitudes of Californians toward poliomyelitis vaccination. American Journal of Public Health 1958, 48(2):146-152.
38. Meyers L. Contact network epidemiology: bond percolation applied to infectious disease prediction and control. Bulletin of the American Mathematical Society 2006, 44:63-86.
39. Miller M., Viboud C., Olson D., Grais R., Rabaa M., Simonsen L. Prioritization of influenza pandemic vaccination to minimize years of life lost. Journal of Infectious Diseases 2008, 198(3):305-311.
40. Miller J. Epidemic size and probability with heterogeneous infectivity and susceptibility. Physical Review E 2007, 76(1). 010101(4).
41. Molinari N.M., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., Bridges C.B. The annual impact of seasonal influenza in the us: measuring disease burden and costs. Vaccine 2007, 25:5086-5096.
42. Mylius S., Hagenaars T., Lugner A., Walling J. Optimal allocation of pandemic influenza vaccine depends on age, risk and timing. Vaccine 2008, 26(29-30):3742-3749.
43. Nichol K.L. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Archives of Internal Medicine 2001, 161(5):749-759.
44. Orenstein E., Serres G.D., Haber M., Shay D., Bridges C., Gargiullo P., Orenstein W. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007, 36(3):623-631.
45. Perisic A., Bauch C.T. Social contact networks and disease eradicability under voluntary vaccination. PLoS Computational Biology 2009, 5(2):e1000280.
46. Perisic A., Bauch C.T. A simulation analysis to characterize the dynamics of vaccinating behaviour on contact networks. BMC Infectious Diseases 2009, 9(77):1-15.
47. Poletti P., Caprile B., Ajelli M., Pugliese A., Merler S. Spontaneous behavioural changes in response to epidemics. Journal of Theoretical Biology 2009, 260(1):31-40.
48. Qiu Z., Feng Z. Transmission dynamics of an influenza model with vaccination and antiviral treatment. Bulletin of Mathematical Biology 2010, 72(1):1-33.
49. Reluga T.C., Bauch C.T., Galvani A.P. Evolving public perceptions and stability in vaccine uptake. Mathematical Biosciences 2006, 204(2):185-198.
50. Rothberg M., Haessler S., Brown R. Complications of viral influenza. The American Journal of Medicine 2008, 121(4):258-264.
51. Salathe M., Bonhoeffer S. The effect of opinion clustering on disease outbreak. Journal of the Royal Society Interface 2008, 5:1505-1508.
52. Salathe M., Khandelwal S. Assessing vaccination sentiments with online social media: implications for infectious disease dynamics and control. PLoS Computational Biology 2011, 7(10):e1002199.
53. Schoenbaum S. Economic impact of influenza: the individual's perspective. The American Journal of Medicine 1987, 82(6A):26-30.
54. Szilagyi P., Bordley C., Vann J., Chelminski A., Kraus R., Margolis P., Rodewald L. Effect of patient reminder/recall interventions on immunization rates. Journal of the American Medical Association 2000, 284(14):1820-1827.
55. Szucs T. The socio-economic burden of influenza. Journal of Antimicrobial Chemotherapy 1999, 44:11-15.
56. Treanor J. Influenza vaccine-outmaneuvering antigenic shift and drift. New England Journal of Medicine 2004, 350:218-220.
57. U.B. of Labor Statistics, 2011. Average annual pay by state and industry. , November. http://www.bls.gov/news.release/annpay.nr0.htm.
58. van Noort S., Aguas R., Ballesteros S., Gomes M. The role of weather on the relation between influenza and influenza-like illness. Journal of Theoretical Biology 2012, 298(7):131-137.
59. Vardavas R., Breban R., Blower S. A universal long-term flu vaccine may not prevent severe epidemics. BMC Research Notes 2010, 3(92).
60. Wells C.R., Tchuenche J., Meyers L., Galvani A.P., Bauch C.T. Impact of imitation processes on the effectiveness of ring vaccination. Bulletin of Mathematical Biology 2011, 73(11):2748-2772.
61. Weycker D., Edelsberg J., Halloran M.E., Longini I.M., Nizam A., Ciuryla V., Oster G. Population-wide benefits of routine vaccination against children against influenza. Vaccine 2005, 23(10):1284-1293.
62. Xia S. Modeling and simulating human vaccinating behaviors on a disease diffusion network. Post Graduate Research Symposium 2009, 1-12. The HKBU Computer Science Department.